Our Leadership

Michael J. Stamos, MD
Dean, UCI School of Medicine

Rebecca Brusuelas-James
Associate Dean, Administration & Finance, UCI School of Medicine

Daniela A. Bota, MD, PhD
Vice Dean for Clinical Research, UCI School of Medicine

Dr. Bota serves as Professor of Neurology and Medical Director for the Neuro-Oncology program at the UCI School of Medicine. She is responsible for overseeing the development of clinical research and the new clinical trials business, guiding the development and implementation of this important initiative. Dr. Bota's proven leadership and passion for research inspires those around her and is a great asset in achieving our collaborative vision for the future of clinical trials at UCI.

Maheswari "Magi" Senthil, MD, FACS
Medical Director, UCI Center for Clinical Research

Dr. Senthil is a clinical professor of surgery and the John Wayne Cancer Foundation endowed chair in the Department of Surgery. She is a nationally recognized surgical oncologist and surgeon-scientist with a special expertise in the management of patients with peritoneal carcinomatosis and advanced malignancies. She is also division chief for surgical oncology in the Department of Surgery, where she leads a strong, multi-institutional translational research program and serves as a primary investigator for many clinical studies, several of which she has initiated. Dr. Senthil’s appointment will provide the governance and leadership, market differentiation and growth, and process oversight and stakeholder experience the CCR will need to continue its upward trajectory and to adapt to the current and future needs of our researchers and the community.

Bruce Albala, PhD
Associate Dean, Innovation & Clinical Trials, UCI School of Medicine
Early Phase Unit Director, UCI Center for Clinical Research

Dr. Albala joined the UCI School of Medicine after 35 years of conducting clinical trials in the private sector. He has served as a principal investigator (PI) or sub-investigator on numerous clinical trials; he owned and operated a 36-bed, Phase I clinical trial inpatient unit; and he served as vice president and head of Clinical Technologies Associates, a specialty contract research organization (CRO).

Beverly Lo Alger, MD, CCRP, CHRC
Director of Clinical Research Operations

Dr. Alger joins UCI from Gilead Sciences, Inc., where she served as regulatory compliance global lead for the Americas and Asia. In this capacity, she was responsible for regulatory compliance and quality oversight worldwide for research and development groups conducting preclinical and clinical research, and pharmacovigilance activities for both investigational and post-approval products. Prior to Gilead Sciences, she served as director of compliance for the City of Hope National Medical Center. Dr. Alger also previously served as the research compliance officer for the UCI Medical Center.